Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial. J of Skin. 2025;9(2):s534. doi:10.25251/skin.10.supp.534